Device type · KWD
Prosthesis, Toe, Hemi-, Phalangeal
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
KWD
Orthopedic
Device class
Class II
FDA decisions since 2015
11
510(k), De Novo and PMA
Adverse event reports
9
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Toe, Hemi-, Phalangeal
- Product code
- KWD
- Device class
- Class II
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3730
- Specialty
- Orthopedic Surgery, Joint Reconstruction
- FDA record
- Classification database entry for KWD
Latest FDA decisions
The 8 newest of 11 since 2015.
K250074 · Decided Apr 3, 2026 · 448 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
- Accu-Joint Hemi Implant510(k)
K240268 · Decided Feb 29, 2024 · 29 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
K221220 · Decided Apr 19, 2023 · 357 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
K222964 · Decided Nov 22, 2022 · 56 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
- restor3d MTP Implant510(k)
K201393 · Decided May 25, 2022 · 728 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
K203634 · Decided Feb 2, 2021 · 53 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
- Accu-Joint Hemi Implant510(k)
K200951 · Decided Dec 8, 2020 · 243 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
- BOSS Toe Fixation System510(k)
K190261 · Decided Aug 14, 2019 · 187 days after receipt
Device type: Prosthesis, Toe, Hemi-, Phalangeal (KWD) · Orthopedic Surgery
Reports received
9
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
2
22% of reports
Injury reports
7
78% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 1 | 0 | 0 |
| Feb 24 | 0 | 2 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 1 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 1 | 125 | 0 | 0 |
| Nov 24 | 2 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 1 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 1 | 0 | 0 | 0 |
| Sep 25 | 1 | 0 | 0 | 0 |
| Oct 25 | 1 | 1 | 0 | 0 |
| Nov 25 | 1 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 2 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 1 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 4 | 0 | 0 |
| Sep 26 | 1 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem3
- Delivered as Unsterile Product1
- Insufficient Device Problem Information1
- No Apparent Adverse Event1
- Off-Label Use1
- Prophylactic removal due to corrective action1
- Use of Device Problem1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Information4
- Pain3
- Arthritis1
- Bone Fracture(s)1
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0264-2027 · Started Sep 4, 2026 · Posted by FDA Oct 22, 2026
Reason given: Implants were found in the field with orange sterilzation indicators which means implants were not exposed to sterilization.
Cause as FDA categorized it: Process change control
Z-0682-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0683-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0684-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0685-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0686-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0687-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Z-0688-2022 · Started Feb 1, 2022
Reason given: There is an incorrect statement regarding MR Compatibility in the BioPro Titanium MPJ implant IFU (IFU BP102303 rev 05) and patient implant cards (22266 rev 00) which indicates that the BioPro MPJ Implant has been tested for safety and compatibility in the MR Environment and is MR Conditional. MR Testing has not been...
Cause as FDA categorized it: Labeling design
Showing the 8 newest of 14 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.